Human diseases, particularly infectious diseases and cancers, pose unprecedented
challenges to public health security and the global economy. The development and …

To adequately prepare for potential hazards caused by emerging and reemerging infectious
diseases, the WHO has issued a list of high-priority pathogens that are likely to cause future …

Human parainfluenza virus type 2 (hPIV2), one of the causative agents of infantile common
cold, is a non‐segmented negative‐sense RNA virus with a robust gene expression system …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as the prime
challenge facing public health safety since 2019. Correspondingly, coronavirus disease …

The mouse paramyxovirus Sendai, which is capable of limited replication in human
bronchial epithelial cells without causing disease, is well suited for the development of …

Introduction The current vaccines used to fight against COVID-19 are effective, however the
induction of protective immunity is a pending goal required to prevent viral transmission …

Objective: Lentinan has antiviral, anti-tumor, immunomodulatory, stimulating interferon
production, and other pharmacological effects. Previous animal experiments have shown …

Several SARS-CoV-2 proteins have been shown to counteract the host innate immune
response, mostly using in vitro protein expression, which may not fully reflect their role in the …

Introduction. Intranasal vaccination using live vector vaccines based on non-pathogenic or
slightly pathogenic viruses is the one of the most convenient, safe and effective ways to …

ABSTRACT Several S RS-CoV-2 proteins have been shown to counteract the host innate
immune response, mostly using in vitro protein expression, which may not fully reflect their …